12/23
09:00 am
artl
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
Low
Report
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
12/3
08:30 am
artl
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical
Medium
Report
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical
11/19
11:02 am
artl
Artelo Biosciences (NASDAQ:ARTL) had its "hold" rating reaffirmed by analysts at Maxim Group.
Low
Report
Artelo Biosciences (NASDAQ:ARTL) had its "hold" rating reaffirmed by analysts at Maxim Group.
11/12
01:24 pm
artl
Artelo Biosciences (NASDAQ:ARTL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Artelo Biosciences (NASDAQ:ARTL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
08:48 am
artl
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/12
08:00 am
artl
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
Medium
Report
Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results